Purchase Order HHSN272201400964P
Award Date 8/29/14
Potential Completion Date 9/12/14
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ireland
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services (HHS), to Aalto Bio Reagents Limited, a for-profit limited liability company. The award, valued at $9,204.00, is for the purchase of 13 vials of 2 mg each of "AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120" at $728.00 per vial. The contract has a firm fixed price and an ultimate completion date of March 31, 2014. The...
- This contract award, with ID HHSN272201400892P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Aalto Bio Reagents LIMITED, a for-profit limited liability company. The $3,935.00 firm fixed-price contract is for the purchase of an unspecified antibody product, with a completion date of September 15, 2014. The contract did not utilize any set-aside designations. Without additional information on the original...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of HIV-1gp120 protein in support of NIAID's preclinical development program. The contract, which does not have a set-aside designation, has a ceiling value of $4,240,924.91 and an ultimate...
- The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $3,731,476.00, is for the NIAID Preclinical Development Support program, specifically to support the production and testing of ADC6-HIV GP140 and ADC7-HIV GP140. The prime contractor is Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods that specializes in the...
- The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,657.20 firm fixed-price purchase order to Ebioscience, Inc., a subsidiary of Affymetrix, Inc., for the supply of monoclonal antibodies, including shipping charges. The contract, which does not have a set-aside designation, was awarded on September 11, 2011, with a completion date of September 19, 2012. This standing order is likely part of NIAID's broader efforts to...
- This is a firm fixed-price purchase order valued at $7,017.50 awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services (HHS) to Affymetrix, Inc. for the delivery of antibodies. The contract does not have a set-aside designation. The award indicates that Affymetrix, Inc. is registered in the System for Award Management (SAM) until March 2018 and is classified as a for-profit manufacturer of goods. No additional details about...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $616,640.51 cost-plus-fixed-fee contract, which is not set aside, supports the "OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT" under NIAID's...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
- <p>The federal contract award HHSN272201401008P was granted to Hycult Biotech Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services. The contract is for the delivery of antibodies, valued at $3,346.75 on a firm fixed price basis. The contract was awarded on September 3, 2014 with an ultimate completion date of October 3, 2014. The contract does not have a set-aside designation.</p>